TFF PHARMACEUTICALS, INC. Research and Development Expense, Software (Excluding Acquired in Process Cost)
TFF PHARMACEUTICALS, INC. reported Research and Development Expense, Software (Excluding Acquired in Process Cost) of $4.02 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost · last filed 2023-05-11
- TFF PHARMACEUTICALS, INC. research and development expense, software (excluding acquired in process cost) for the quarter ending 2023-03-31 was $4.02M, a 23.27% decline year-over-year.
- TFF PHARMACEUTICALS, INC. research and development expense, software (excluding acquired in process cost) for the quarter ending 2022-03-31 was $5.24M.
| Period end | Research and Development Expense, Software (Excluding Acquired in Process Cost) 3 month |
|---|---|
| 2023-03-31 | $4.02M 10-Q · filed 2023-05-11 |
| 2022-03-31 | $5.24M 10-Q · filed 2023-05-11 |